Cost-Effectiveness Analysis Of Cetuximab And Panitumumab For First Line Treatment Of Metastatic Colorectal Cancer (Mcrc) In Wt Ras Patients In Spain
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.1187
https://www.valueinhealthjournal.com/article/S1098-3015(15)03263-5/fulltext
Title :
Cost-Effectiveness Analysis Of Cetuximab And Panitumumab For First Line Treatment Of Metastatic Colorectal Cancer (Mcrc) In Wt Ras Patients In Spain
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03263-5&doi=10.1016/j.jval.2015.09.1187
First page :
A460
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
686